Literature DB >> 732815

The effect of a pyrrolizidine alkaloid, monocrotaline, and a pyrrole, dehydroretronecine, on the biochemical functions of the pulmonary endothelium.

R Huxtable, D Ciaramitaro, D Eisenstein.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 732815

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


× No keyword cloud information.
  12 in total

1.  Alteration of fate of vasoactive autacoids in pulmonary circulation following monocrotaline-induced lung vascular injury in rats.

Authors:  K Ito; K Hayashi; T Nakashima; T Murakami
Journal:  Br J Pharmacol       Date:  1988-08       Impact factor: 8.739

2.  Lung angiotensin converting enzyme activity in monocrotaline pulmonary hypertension.

Authors:  P M Keane; J M Kay
Journal:  Thorax       Date:  1984-02       Impact factor: 9.139

3.  Changes in angiotensin-converting enzyme activity in lungs damaged by the pyrrolizidine alkaloid monocrotaline.

Authors:  W M Lafranconi; R J Huxtable
Journal:  Thorax       Date:  1983-04       Impact factor: 9.139

4.  Effect of monocrotaline ingestion on the distribution of protein and angiotensin converting enzyme activity in the rat lung.

Authors:  D J Shale; M S Wiseman; W O Cookson
Journal:  Thorax       Date:  1986-12       Impact factor: 9.139

Review 5.  Effects of changes in pulmonary perfusion and surface area on endothelial ACE activity.

Authors:  B R Pitt; G Lister; P Davies; L M Reid
Journal:  Ann Biomed Eng       Date:  1987       Impact factor: 3.934

6.  Increased TMEM16A-encoded calcium-activated chloride channel activity is associated with pulmonary hypertension.

Authors:  Abigail S Forrest; Talia C Joyce; Marissa L Huebner; Ramon J Ayon; Michael Wiwchar; John Joyce; Natalie Freitas; Alison J Davis; Linda Ye; Dayue D Duan; Cherie A Singer; Maria L Valencik; Iain A Greenwood; Normand Leblanc
Journal:  Am J Physiol Cell Physiol       Date:  2012-10-03       Impact factor: 4.249

7.  Lung angiotensin converting enzyme activity in rats with pulmonary hypertension.

Authors:  P M Keane; J M Kay; K L Suyama; D Gauthier; K Andrew
Journal:  Thorax       Date:  1982-03       Impact factor: 9.139

8.  Angiotensin converting enzyme activity and evolution of pulmonary vascular disease in rats with monocrotaline pulmonary hypertension.

Authors:  J M Kay; P M Keane; K L Suyama; D Gauthier
Journal:  Thorax       Date:  1982-02       Impact factor: 9.139

Review 9.  Bone marrow-derived vascular modulatory cells in pulmonary arterial hypertension.

Authors:  Emily Lanzola; Samar Farha; Serpil C Erzurum; Kewal Asosingh
Journal:  Pulm Circ       Date:  2013-12       Impact factor: 3.017

10.  Crotalaria-induced pulmonary hypertension. Uptake of 3H-thymidine by the cells of the pulmonary circulation and alveolar walls.

Authors:  B O Meyrick; L M Reid
Journal:  Am J Pathol       Date:  1982-01       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.